Legislator Jurisprudence & Législation
812.21 CH-JU

Art. 4 Loi sur la vente des médicaments

8. Santé, travail, sécurité sociale » 81. Santé » 812. Substances thérapeutiques, stupéfiants et poisons
Ouvrir la source officielle Texte complet (16 Articles) Version Markdown lisible par machine (.md)

Art. 4 Loi sur la vente des médicaments

Le Département de la Santé et des Affaires sociales (dénommé ci-après : "Département") octroie les autorisations.

← Art. 3 Loi sur la vente des médicaments 8. Santé, travail, sécurité sociale » 81. Santé » 812. Substances thérapeutiques, stupéfiants et poisons Art. 5 Loi sur la vente des médicaments →

Vous souhaitez savoir comment cette disposition s'applique à votre dossier ?

Analysez ce texte législatif avec la jurisprudence, la doctrine et les dispositions connexes dans Legislator AI.

Ouvrir dans Legislator →

Décisions judiciaires appliquant cette disposition (31)

BGE 150 V 210 (Art. 4 Abs. 1 lit. a und c HMG)
Reimbursement of hospital pharmacy compounding tax for aseptically prepared cytostatic infusions under Swiss mandatory health insurance
Defines the terms 'medicinal product' and 'manufacturing', used to determine that the preparation constitutes manufacturing covered by the tariff.
BV.2024.30 (art. 4 al. 1 LPTh)
Swissmedic Seizure of Unapproved Medications Upheld
Cited to define what constitutes a medicinal product under the law.
BV.2022.9 (art. 4 al. 1 let. a LPTh)
Swissmedic Property Seizure Upheld in Unapproved Product Sales Case
Defines what constitutes a medicinal product, relevant for classifying the imported items.
SG.2019.7 · bs (Art. 4 Abs. 1 lit. a HMG)
Aseptic Compounding Fees for Cytostatics vs. Principle of Economy
Cited in the reasoning (point 2.1) for the definition of 'Arzneimittel' (medicines).
SG.2019.7 · bs (Art. 4 Abs. 1 lit. c HMG)
Aseptic Compounding Fees for Cytostatics vs. Principle of Economy
Cited in the reasoning (point 4.3.1 and 4.4.3) for the definition of 'Herstellen' (manufacturing) of medicines.
B-3361/2020 (Art. 4 al. 1 let. a LPTh)
Veterinary Medicine Classification Upheld for Permethrin Insect Treatment
Used to define what constitutes a veterinary medicinal product and classify the product 'A._______' as such.
C-1168/2018 (Art. 4 al. 1 let. a LPTh)
Recipient Liable for Fees on Illegal Drug Importation Despite Denial
Defines what constitutes a 'medicament' for the purposes of the law, relevant to classifying the imported substances.
200 2019 102 · be (Art. 4 Abs. 1 lit. a HMG)
Insurer Refusal to Cover Delisted Leukemia Drug Upheld Due to Available Alternative
Cited in the reasoning to define what constitutes an 'Arzneimittel' (medicament), but not in the final orders.
C-1748/2014 (Art. 4 cpv. 1 lett. a LATer)
Graviola Leaf Powder: Medicinal Product or Food Supplement
Definition of a medicine, used to classify the graviola powder as such.
C-5689/2013 (art. 4 let. b LPTh)
Frequency Patch Marketing Deemed Medical Device Use
Cited to define what constitutes a medical device.
A/2738/2016 · ge (art. 4 al. 1 let. a LPTh)
Patient Appeal Regarding Food Supplement Sales and Urinary Care Dismissed
Cited to define 'medication' for the purpose of assessing the prohibition on sale by a doctor.
C-3525/2012 (Art. 4 Abs. 1 lit. a HMG)
Herbal Bitter Classified as Medicine, Not Food
This provision is used to define 'Arzneimittel' (medicinal product) and justify the classification of the product as such, leading to the dismissal of the application.
C-4612/2011 (Art. 4 Bst. a HMG)
Pet Food vs. Veterinary Medicine Classification
Cited in the context of defining a health product claim, which was relevant to the product's classification.
C-546/2010 (Art. 4 Abs. 2 HMG)
Swissmedic v. Aesthetics Company: Advertising Ban and Website Modifications
Cited as the legal basis for the Federal Council to issue ordinances on medicinal product advertising.
BE.2013.9 (Art. 4 al. 1 let. c LPTh)
Swissmedic v. Pharmaceutical Company (Sealed Documents)
This provision is cited to define 'fabrication' in the context of therapeutic products, relevant to the alleged infractions.